Sharecare (NASDAQ:SHCR – Get Rating) had its price objective dropped by stock analysts at Morgan Stanley from $2.50 to $2.00 in a report issued on Thursday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Morgan Stanley’s price target points to a potential upside of 36.99% from the company’s current price.
Sharecare Price Performance
→ Biden To Unleash “Choke Point” Operation On America? (From Investor Place Media)
Shares of NASDAQ SHCR opened at $1.46 on Thursday. The stock has a market capitalization of $516.14 million, a P/E ratio of -5.84 and a beta of 0.42. Sharecare has a one year low of $1.38 and a one year high of $3.43. The firm’s 50 day simple moving average is $2.37 and its two-hundred day simple moving average is $2.05.
Institutional Trading of Sharecare
Institutional investors have recently made changes to their positions in the stock. Orin Green Financial LLC purchased a new stake in Sharecare in the fourth quarter worth $25,000. WealthPLAN Partners LLC bought a new position in shares of Sharecare during the fourth quarter valued at $3,013,000. Alliancebernstein L.P. increased its holdings in Sharecare by 74.7% in the 4th quarter. Alliancebernstein L.P. now owns 150,600 shares of the company’s stock worth $241,000 after buying an additional 64,400 shares in the last quarter. State of Wyoming increased its holdings in Sharecare by 51.8% in the 4th quarter. State of Wyoming now owns 82,439 shares of the company’s stock worth $132,000 after buying an additional 28,122 shares in the last quarter. Finally, Mackenzie Financial Corp bought a new stake in Sharecare in the 4th quarter worth about $30,000. Hedge funds and other institutional investors own 34.22% of the company’s stock.
About Sharecare
Sharecare, Inc operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to enhance their health and well-being.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sharecare, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Sharecare wasn’t on the list.
While Sharecare currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: marketbeat.com
